In vitro inhibition of human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by grandisin (2017)
- Authors:
- USP affiliated authors: LOPES, NORBERTO PEPORINE - FCFRP ; OLIVEIRA, ANDERSON RODRIGO MORAES DE - FFCLRP
- Unidades: FCFRP; FFCLRP
- DOI: 10.1055/s-0042-124615
- Subjects: PRODUTOS NATURAIS; CITOCROMO P-450; FÍGADO; INIBIDORES DE ENZIMAS
- Keywords: Cytochrome p450 inhibition; Grandisin; Drug interactions; Human liver microsomes; Mechanism-based inhibition
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Planta Medica
- ISSN: 0032-0943
- Volume/Número/Paginação/Ano: v. 83, p. 727-736, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HABENSCHUS, Maísa Daniela et al. In vitro inhibition of human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by grandisin. Planta Medica, v. 83, p. 727-736, 2017Tradução . . Disponível em: https://doi.org/10.1055/s-0042-124615. Acesso em: 11 fev. 2026. -
APA
Habenschus, M. D., Moreira, F. de L., Lopes, N. P., & Oliveira, A. R. M. de. (2017). In vitro inhibition of human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by grandisin. Planta Medica, 83, 727-736. doi:10.1055/s-0042-124615 -
NLM
Habenschus MD, Moreira F de L, Lopes NP, Oliveira ARM de. In vitro inhibition of human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by grandisin [Internet]. Planta Medica. 2017 ; 83 727-736.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1055/s-0042-124615 -
Vancouver
Habenschus MD, Moreira F de L, Lopes NP, Oliveira ARM de. In vitro inhibition of human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by grandisin [Internet]. Planta Medica. 2017 ; 83 727-736.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1055/s-0042-124615 - Analytical tools the enantioselective analysis of drugs and metabolites
- A non-michaelian behavior of the in vitro metabolism of the pentacyclic triterpene alfa and beta amyrins by employing rat liver microsomes
- In vitro metabolism studies of natural products are crucial in the early development of medicines
- In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes
- In vitro metabolism and cytotoxicity of parthenolide: the complete identification of the major oxidative product and the evaluation of trypanocidal and leishmanicidal activities
- Biomimetic metabolism of Kaurenoic acid validated by microsomal reactions
- Validation of an HPLC-UV method for in vitro metabolism studies of Casearin X
- Microsomal metabolism of erythraline: an anxiolitic spiroalkaloid
- Formation of a predominant metabolite of hydroxydihydrocarvone evaluated by a biomimetic oxidative model and in rat liver microsomes
- Evaluation of the intestinal absorption mechanism of casearin X in caco-2 cells with modified carboxylesterase activity
Informações sobre o DOI: 10.1055/s-0042-124615 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
